A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| CIL56 | CIL56 is a potent and selective ferroptosis inducer. Ferroptosis is an iron-dependent form of regulated cell death (RCD). Uses: Scientific research. Group: Signaling pathways. CAS No. 300802-28-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-112063. |  |
| Cilantro (Coriander Leaf) Herb Powder | Cilantro (Coriander Leaf) Herb Powder. |  CA, FL & NJ |
| Cilastatin | Cilastatin can prevent renal metabolism of penem and carbapenem antibiotics by specific and reversible dehydropeptidase I inhibition. It can be used as antibacterial adjunct. Uses: Antibacterial adjunct. Synonyms: (2Z)-7-[[(2R)-2-amino-2-carboxyethyl]thio]-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic Acid; MK-791; MK 791; MK791. Grade: >95%. CAS No. 82009-34-5. Molecular formula: C16H26N2O5S. Mole weight: 358.45. |  |
| Cilastatin | Cilastatin (MK0791) is a reversible, competitive renal dehydropeptidase I inhibitor with an IC50 of 0.1 μM. Cilastatin inhibits the bacterial metallob-lactamase enzyme CphA with an IC50 of 178 μM. Cilastatin is an antibacterial adjunct. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Cilastatin. Product Category: Inhibitors. Appearance: White to Light-Yellow Crystalline Powder. CAS No. 82009-34-5. Molecular formula: C16H26N2O5S. Mole weight: 358.45. Purity: 0.9937. Density: 1.275 g/cm³. Product ID: ACM82009345. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Cilastatin | Cilastatin (MK0791) is a reversible, competitive renal dehydropeptidase I inhibitor with an IC 50 of 0.1 μM. Cilastatin inhibits the bacterial metallob-lactamase enzyme CphA with an IC 50 of 178 μM. Cilastatin is an antibacterial adjunct [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: MK0791. CAS No. 82009-34-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-A0166. | |
| Cilastatin | Prevents renal metabolism of penem and carbapenem antibiotics by specific and reversible dehydropeptidase I inhibition. Antibacterial adjunct.Cilastatin is an inhibitor of dipeptidase (dehydropeptidase I), a renal dipeptidase.1 It inhibits human renal dipeptidase (Ki = 0.7uM), porcine dipeptidase (IC50 = 0.11uM), and bacterial metallo- β-lactamase CphA from A. hydrophila (IC50 = 178uM).1,2,3 Cilastatin (200ug/ml) protects primary porcine renal proximal tubular epithelial cells from nephrotoxicity and apoptosis induced by vancomycin.4 In a mouse model of systemic infection, cilastatin in combination with imipenem protects mice from S. aureus, E. coli, and P. aeruginosa infection.5 Cilastatin was designed to inhibit renal metabolism of imipenem and prolong its half-life.2 Formulations containing cilastatin in combination with imipenem have been used to treat susceptible bacterial infections. Group: Biochemicals. Alternative Names: (2Z) -7- [ [ (2R) -2-amino-2-carboxyethyl] thio] -2- [ [ [ (1S) -2, 2-dimethylcyclopropyl] carbonyl] amino] -2-heptenoic Acid; MK-791. Grades: Highly Purified. CAS No. 82009-34-5. Pack Sizes: 10mg, 25mg, 50mg, 100mg. Molecular Formula: C??H??N?O?S, Molecular Weight: 358.45. US Biological Life Sciences. |  Worldwide |
| Cilastatin ammonium salt | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. |  |
| Cilastatin Ammonium Salt | Cilastatin Ammonium Salt is the ammonium salt of Cilastatin, which is a dipeptidase inhibitor of renal enzyme dehydropeptidase-I and leukotriene D4 peptidase. It inhibits metabolism of LTD4 to LTE4 and the hydrolysis of β-lactam antibiotics. It reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells. It can be combined intravenously with imipenem in order to protect it from dehydropeptidase. It suppresses both host and target metabolism of the broad-spectrum antibiotic imipenem, improving its efficacy. It usually confers antibiotic resistance to certain bacteria because itself does not have antibiotic activity. It has nephroprotective effects. Synonyms: (2Z)-7-[[(2R)-2-amino-2-carboxyethyl]thio]-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic Acid Ammonium Salt; MK-791 Ammonium Salt. Grade: > 95%. CAS No. 877674-82-3. Molecular formula: C16H29N3O5S. Mole weight: 375.48. | |
| Cilastatin Enantiomer | Cilastatin Enantiomer. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (Z)-7-(((S)-2-amino-2-carboxyethyl)thio)-2-((R)-2,2-dimethylcyclopropanecarboxamido)hept-2-enoic acid. CAS No. 107872-24-2. Molecular formula: C16H26N2O5S. Mole weight: 358.45. Catalog: APB107872242. | |
| Cilastatin Impurity 2 | Cilastatin Impurity 2. Uses: For analytical and research use. Group: Impurity standards. CAS No. 107873-05-2. Molecular formula: C16H26N2O5S. Mole weight: 358.45. Catalog: APB107873052. | |
| Cilastatin Impurity 4 | Cilastatin Impurity 4. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1401730-23-1. Molecular formula: C15H24BrNO3. Mole weight: 346.26. Catalog: APB1401730231. | |
| Cilastatin sodium | Cilastatin sodium (MK0791 sodium) is a reversible, competitive renal dehydropeptidase I inhibitor with an IC 50 of 0.1 μM. Cilastatin sodium inhibits the bacterial metallob-lactamase enzyme CphA with an IC 50 of 178 μM. Cilastatin sodium is an antibacterial adjunct [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: MK0791 sodium. CAS No. 81129-83-1. Pack Sizes: 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-A0166A. | |
| Cilastatin sodium | Cilastatin sodium. Group: Biochemicals. Grades: Highly Purified. CAS No. 81129-83-1. Pack Sizes: 100mg, 250mg, 500mg, 1g, 2g. Molecular Formula: C16H25N2NaO5S. US Biological Life Sciences. | Worldwide |
| Cilastatin sodium | Cilastatin sodium (MK0791 sodium) is a reversible, competitive renal dehydropeptidase I inhibitor with an IC50 of 0.1 μM. Cilastatin sodium inhibits the bacterial metallob-lactamase enzyme CphA with an IC50 of 178 μM. Cilastatin sodium is an antibacterial adjunct. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 2-heptenoicacid,7-((2-amino-2-carboxyethyl)thio)-2-(((2,2-dimethylcyclopropyl;l642957;monosodiumsalt,(r-(r*,s*(z)))-)carbonyl)amino);sodium hydrogen [R-[R*,S*-(Z)]]-7-[(2-amino-2-carboxylatoethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]hept-2-enoate;Cilastatine;Cilastatin sodium;Sodium 7-(2-amino-2-carboxy-ethyl)sulfanyl-2-(2,2-dimethylcyclopropyl)carbonylamino-hept-2-enoate;Sodium hydrogen 7-[(2-amino-2-carboxylatoethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]hept-2-enoate. Product Category: Inhibitors. Appearance: A white colour powder. CAS No. 81129-83-1. Molecular formula: C16H25N2O5S.Na. Mole weight: 380.44. Purity: 95%+. IUPACName: sodium;(Z)-7-[(2R)-2-amino-2-carboxyethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoate. Canonical SMILES: CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)[O-])C.[Na+]. ECNumber: 279-694-4. Product ID: ACM81129831. Alfa Chemistry ISO 9001:2015 Certified. | |
| Cilastatin sodium | Cilastatin sodium is the sodium salt of cilastatin, which is a dipeptidase inhibitor of renal enzyme dehydropeptidase-I and leukotriene D4 peptidase. It inhibits metabolism of LTD4 to LTE4 and the hydrolysis of β-lactam antibiotics. It reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells. It can be combined intravenously with imipenem in order to protect it from dehydropeptidase. It suppresses both host and target metabolism of the broad-spectrum antibiotic imipenem, improving its efficacy. It usually confers antibiotic resistance to certain bacteria because itself does not have antibiotic activity. It has nephroprotective effects. Synonyms: L 642957; MK 791; L642957; MK791; L-642957; MK-791; [R-[R*,S*-(Z)]]-7-[(2-Amino-2-carboxyethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]-2-heptenoic Acid Monosodium Salt; (2Z)?-7-[[(2R)?-2-Amino-2-carboxyethyl]?thio]?-2-[[[(1S)?-2,?2-dimethylcyclopropyl]?carbonyl]?amino]?-2-heptenoic Acid Sodium Salt; sodium S-((Z)-6-carboxy-6-((S)-2,2-dimethylcyclopropane-1-carboxamido)hex-5-en-1-yl)-L-cysteinate. Grade: 98%. CAS No. 81129-83-1. Molecular formula: C16H25N2NaO5S. Mole weight: 380.43. | |
| Cilastatin sodium Ready Made Solution | 50 mg/mL in H2O. Group: Fluorescence/luminescence spectroscopy. | |
| Cilazapril | An ACE inhibitor. Hydrolyzed in vivo to the active diacid metabolite (Cilazaprilat). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Cilazapril | Cilazapril is a very potent and highly effective angiotensin-converting enzyme inhibitor (ACE inhibitor). It is used for the treatment of hypertension and congestive heart failure. lt is a monoethyl ester. It is a prodrug that is hydrolyzed after absorption to its main metabolite cilazaprilat by non-specific esterases. It is known that the diacid form is more potent. It has been listed. Uses: Cilazapri is used for the treatment of hypertension and congestive heart failure. Synonyms: Cilazapril; Ro 34-2848; Ro-34-2848; Ro34-2848. 7-[(2-amino-2-carboxylatoethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]hept-2-enoate; 6H-Pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid, 9-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]octahydro-10-oxo-, (1S,9S)-; 6H-Pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid, 9-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]octahydro-10-oxo-, [1S-[1α,9α(R*)]]-; Ro 31-2848; (1S,9S)-9-[(S)-1-Ethoxycarbonyl-3-phenylpropylamino]-10-oxoperhydropyridazino[1,2-a][1,2]diazepine-1-carboxylic acid; Inhibace; Vascace; Cilazaprilum; (4S,7S)-7-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid. Grade: >98%. CAS No. 88768-40-5. Molecular formula: C22H31N3O5. Mole weight: 417.50. | |
| Cilazaprilat | Cilazaprilat is the active metabolite of Cilazapril. It is an ACE inhibitor. Cilazaprilat shows antihypertensive activity. Uses: Antihypertensive agents. Synonyms: (1S,9S)-9-[[(1S)-1-Carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic Acid; Ro 31-3113. Grade: > 95%. CAS No. 90139-06-3. Molecular formula: C20H27N3O5. Mole weight: 389.45. | |
| Cilazaprilat | Cilazaprilat. Uses: Designed for use in research and industrial production. Additional or Alternative Names: CILAZAPRILAT HYDRATE;(1S,9S)-9-[[(1S)-1-Carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-α][1,2]diazepine-1-carboxylic Acid;Ro 31-3113;(1S,9S)-9-[[(1S)-1-Carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-ca. Product Category: Heterocyclic Organic Compound. Appearance: White to Off-White Solid. CAS No. 90139-06-3. Molecular formula: C20H27N3O5. Mole weight: 389.44. Product ID: ACM90139063. Alfa Chemistry ISO 9001:2015 Certified. | |
| Cilazaprilat | An ACE inhibitor. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Cilazapril EP Impurity A | Cilazapril EP Impurity A. Uses: For analytical and research use. Group: Impurity standards. CAS No. 106860-19-9. Molecular formula: C26H39N3O5. Mole weight: 473.61. Catalog: APB106860199. | |
| Cilazapril EP Impurity D | Cilazapril EP Impurity D. Uses: For analytical and research use. Group: Impurity standards. CAS No. 106928-09-0. Molecular formula: C22H31N3O5. Mole weight: 417.51. Catalog: APB106928090. | |
| Cilazapril Impurity 1 | Cilazapril Impurity 1. Uses: For analytical and research use. Group: Impurity standards. CAS No. 124620-51-5. Molecular formula: C17H25NO5. Mole weight: 323.39. Catalog: APB124620515. | |
| Cilazapril monohydrate | Cilazapril Monohydrate is a angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure. Uses: Scientific research. Group: Signaling pathways. Alternative Names: Ro 31-2848 monohydrate. CAS No. 92077-78-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-A0043A. | |
| Cilazapril Monohydrate | Cilazapril is a angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure. Uses: Angiotensin-converting enzyme inhibitors. Synonyms: CILAZAPRIL MONOHYDRATE; 6H-Pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, 9-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)octahydro-10-oxo-, monohydrate, (1S-(1alpha,9alpha(R*)))-; 6H-Pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, octahydro-9-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-10-oxo-, hydrate, (1S-(1-alpha,9-alpha(R*)))-; MS-27800; D01069; Q27252108; (1S,9S)-9-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid hydrate; (1S,9S)-9-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid--water (1/1); 6H-PYRIDAZINO(1,2-A)(1,2)DIAZEPINE-1-CARBOXYLIC ACID, 9-((1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)AMINO)OCTAHYDRO-10-OXO-, MONOHYDRATE, (1S-(1.ALPHA.,9.ALPHA.A(R*)))-. Grade: >98%. CAS No. 92077-78-6. Molecular formula: C22H33N3O6. Mole weight: 435.51. | |
| Cilazapril N-Nitroso Impurity | Cilazapril N-Nitroso Impurity. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1053740-92-3. Molecular formula: C22H30N4O6. Mole weight: 446.5. Catalog: APB1053740923. | |
| Cilengitide | Cilengitide is a cyclic Arg-Gly-Asp peptide with potential antineoplastic activity. Cilengitide binds to and inhibits the activities of the alpha(V)beta(3) and alpha(V)beta(5) integrins, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. It is being studied for the treatment of glioblastoma. Synonyms: 2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid. Grade: ≥98%. CAS No. 188968-51-6. Molecular formula: C27H40N8O7. Mole weight: 588.65. | |
| Cilengitide | Cilengitide (EMD 121974) is a potent integrins antagonist with IC50s of 0.61 nM (???3), 8.4 nM (???5) and 14.9 nM (?5?1), respectively. Cilengitide inhibits the binding of ???3 and ???5 to Vitronectin with IC50s of 4 nM and 79 nM, respectively. Cilengitide inhibits TGF-?/Smad signaling, mediates PD-L1 expression. Cilengitide also induces apoptosis, shows antiangiogenic effect in the research against glioblastoma and other cancers[1][2][3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: EMD 121974. CAS No. 188968-51-6. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-16141. | |
| Cilengitide TFA | Cilengitide is a potent and selective integrin inhibitor for ?v?3 and ?v?5 receptor, with IC50 values of 4 nM and 79 nM, respectively. Uses: Scientific research. Group: Signaling pathways. Alternative Names: EMD 121974 TFA. CAS No. 199807-35-7. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-16143. | |
| Cilengitide TFA salt | Cilengitide TFA salt, is a cyclic Arg-Gly-Asp acid pentapeptide that induces anoikis in angiogenic blood vessels and brain tumor, selectively and potently blocks the ligation of theαvβ3 andαvβ5 integrins to provisional matrix proteins such as vitronectin, fibronectin, fibrinogen, von Willebrand factor, osteopontin, and others. Synonyms: Cilengitide trifluoroacetate. Grade: >98%. CAS No. 199807-35-7. Molecular formula: C29H41F3N8O9. Mole weight: 702.68. | |
| Cilengitide trifluoroacetic acid salt | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Cilgavimab | Cilgavimab (AZD-1061; COV2-2130) is a human SARS-CoV-2 -neutralizing monoclonal antibody, can compose monoclonal-antibody combination AZD7442 with Tixagevimab (HY-P99556). Cilgavimab shows protective action on mouse models of SARS-CoV-2 infection [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: AZD-1061; COV2-2130. CAS No. 2420563-99-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99604. | |
| Ciliobrevin A | Ciliobrevin A is a Hedgehog pathway inhibitor; ciliogenesis inhibitor. The Hedgehog (HH) signaling pathway is targeted for anti-cancer therapeutics. Ciliobrevin A inhibited proliferation of cerebellar granula neuron precursor cells, an important model of HH signaling. Group: Biochemicals. Alternative Names: 2,4-Dichloro-α-(3,4-dihydro-4-oxo-2(1H)-quinazolinylidene)- β -oxo Benzene propanenitrile; HPI-4. Grades: Highly Purified. CAS No. 302803-72-1. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Ciliobrevin A | Ciliobrevin A is a Hedgehog (Hh) pathway inhibitor that blocks Hh pathway activation and decreases Smo ciliary accumulation in a constitutively active Hh cell line. It perturbs primary cilia formation, leads to disruption of Gli1/Gli2 activity, and suppresses primary cilia-related protein intraflagellar transport protein IFT88 expression. It inhibits cell proliferation, invasion and migration ability in human chondrosarcoma. Synonyms: HPI-4; Hedgehog Pathway Inhibitor 4; (E)-3-(2,4-dichlorophenyl)-3-oxo-2-(4-oxo-3,4-dihydroquinazolin-2(1H)-ylidene)propanenitrile. Grade: >98%. CAS No. 302803-72-1. Molecular formula: C17H9Cl2N3O2. Mole weight: 358.18. | |
| Ciliobrevin A | Ciliobrevin A (HPI-4) is a hedgehog (Hh) signaling pathway inhibitor with median inhibitory concentration (IC50) less than 10 ?M[1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: HPI-4. CAS No. 302803-72-1. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-100790. | |
| Ciliobrevin D | Ciliobrevin D is a cell-permeable, reversible and specific inhibitor of AAA+ ATPase motor cytoplasmic dynein. Ciliobrevin D inhibits Hedgehog (Hh) signaling and primary cilia formation. Ciliobrevin D inhibits dynein-dependent microtubule gliding and ATPase activity in vitro[1][2]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1370554-01-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-122632. | |
| Ciliobrevin D | Ciliobrevin D is an inhibitor of dynein ATPase activity that prevents the cycling activity of the motor protein. It inhibits the bi-directional transport of organelles along sensory axons and impairs NGF-mediated regulation of growth cones and axon branches. CAS No. 1370554-01-0. Molecular formula: C17H8Cl3N3O2. Mole weight: 392.62. | |
| Cilnidipine | Cilnidipine. Group: Biochemicals. Alternative Names: 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl (2E)-3-phenyl-2-propenyl ester, FRC-8653, atelec, cinalong, siscard. Grades: Highly Purified. CAS No. 132203-70-4. Pack Sizes: 500mg, 1g, 2g, 5g, 10g. Molecular Formula: C27H28N2O7. US Biological Life Sciences. | Worldwide |
| Cilnidipine | Cilnidipine is a unique L-type and N-type calcium channel blocker, used for high blood pressure treatment. Uses: Calcium channel blockers. Synonyms: FRC-8653; FRC 8653; FRC8653; Cilnidipine; Atelec; Cinalong; Siscard. Grade: >98%. CAS No. 132203-70-4. Molecular formula: C27H28N2O7. Mole weight: 492.52. | |
| Cilnidipine | Cilnidipine is a long-acting, second-generation dihydropyridine Ca 2+ -channel blocker on L and N-type Ca 2+ channel [1] [2] [3] [4]. Antihypertensive effects [5]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: FRC-8653. CAS No. 132203-70-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-17404. | |
| Cilnidipine | ?98% (HPLC), powder. Group: Fluorescence/luminescence spectroscopy. | |
| Cilnidipine (1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-Methoxyethyl (2E)-3-Phenyl-2-propenyl Ester, FRC-8653, Atelec, Cinalong, Siscard,) | A dihydropyridine calcium channel blocker. Group: Biochemicals. Alternative Names: 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-Methoxyethyl (2E)-3-Phenyl-2-propenyl Ester, FRC-8653, Atelec, Cinalong, Siscard. Grades: Highly Purified. Pack Sizes: 25mg. US Biological Life Sciences. | Worldwide |
| Cilnidipine Impurity 2 | Cilnidipine Impurity 2. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-5-((cinnamyloxy)carbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid. CAS No. 123853-41-8. Molecular formula: C24H22N2O6. Mole weight: 434.44. Catalog: APB123853418. | |
| Cilnidipine Impurity 5 | Cilnidipine Impurity 5. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-cinnamyl 3-aminobut-2-enoate. CAS No. 103909-86-0. Molecular formula: C13H15NO2. Mole weight: 217.26. Catalog: APB103909860. | |
| Cilobradine hydrochloride | Cilobradine hydrochloride, also called as DK-AH 269, a benzazepinone derivative, is an HCN Channel blocker that might be beneficial in the treatment of cardiovascular diseases, e.g. ischemia. Synonyms: 3-[[(3S)-1-[2-(3,4-dimethoxyphenyl)ethyl]piperidin-3-yl]methyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one; hydrochloride 1,3,4,5-tetrahydro-7,8-dimethoxy-3-((1-(2-(3,4-dimethoxyphenyl)ethyl)-3-piperidinyl)methyl)-2H-3-benzazepin-2-one hydrochloride D. CAS No. 186097-54-1. Molecular formula: C28H39ClN2O5. Mole weight: 519.07. | |
| Cilofexor | Cilofexor is a farnesoid X receptor (FXR) agonist. Cilofexor inhibits binding of a synthetic peptide, comprising residues 676-700 of the steroid receptor coactivator 1 (SRC-1), to the farnesoid X receptor (FXR; EC50 = <25 nM in a FRET activity assay). Synonyms: 2-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl]methoxy]phenyl]-3-hydroxy-1-azetidinyl]-4-pyridinecarboxylic acid. Grade: ≥98%. CAS No. 1418274-28-8. Molecular formula: C28H22Cl3N3O5. Mole weight: 586.9. | |
| Cilofexor | Cilofexor (GS-9674) is a potent, selective and orally active nonsteroidal FXR agonist with an EC 50 of 43 nM. Cilofexor has anti-inflammatory and antifibrotic effects. Cilofexor has the potential for primary sclerosing cholangitis (PSC) and nonalcoholic steatohepatitis (NASH) research [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: GS-9674. CAS No. 1418274-28-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-109083. | |
| Cilomilast | Cilomilast (SB-207499) is a potent, selective and orally active inhibitor of Phosphodiesterase 4 (PDE4) , with IC 50 s of ~100 and 120 nM for LPDE4 and HPDE4, respectively. Cilomilast shows selectivity for PDE4 over PDE1, PDE2, PDE3 and PDE5 ( IC 50=74, 65, >100, and 83 μM, respectively). Cilomilast has anti-inflammatory and immunomodulatory effects and can be used for thr research of asthma and chronic obstructive pulmonary disease (COPD) [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: SB-207499. CAS No. 153259-65-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-10790. | |
| Cilomilast | Cilomilast. Group: Biochemicals. Alternative Names: cis-4-Cyano-4- [3- (cyclopentyloxy) -4-methoxyphenyl] cyclohexanecarboxylic acid; cis-4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-4-cyanocyclohexane-1-carboxylic acid; Ariflo. Grades: Highly Purified. CAS No. 153259-65-5. Pack Sizes: 2mg, 5mg, 10mg, 25mg, 50mg. Molecular Formula: C20H25NO4. US Biological Life Sciences. | Worldwide |
| Cilomilast | Selective phosphodiesterase 4 (PDE4) inhibitor. Antiasthmatic; used in treatment of chronic obstructive pulmonary disease. Uses: Phosphodiesterase 4 inhibitors. Synonyms: SB 207499; SB-207499; SB207499. Cilomilast; Ariflo. Grade: 0.98. CAS No. 153259-65-5. Molecular formula: C20H25NO4. Mole weight: 343.423. | |
| Cilomilast | ?95% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Cilomilast-d5 | An isotope labelled of Cilomilast. Cilomilast is a selective phosphodiesterase-4 inhibitor and can be used for the treatment of respiratory disorders. Grade: 95% by HPLC; 98% atom D. Molecular formula: C20H20D5NO4. Mole weight: 348.45. | |
| Cilostamide | Cilostamide is a selective and potent PDE3 inhibitor, with IC50s of 27 nM and 50 nM for PDE3A and PDE3B, respectively, and has antithrombotic and anti-intimal hyperplastic activity. Uses: Scientific research. Group: Signaling pathways. Alternative Names: OPC3689. CAS No. 68550-75-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-101312. | |
| Cilostamide | Cilostamide is a selective and specific inhibitor of type III phosphodiesterase (PDE3). It shows moderate selectivity for PDE3A isozyme and PDE3B. It increases intracellular cAMP and inhibits ADP-induced platelet aggregation. It has an antithrombotic effect. Uses: Phosphodiesterase inhibitors. Synonyms: Cilostamide; OPC 3689; OPC-3689; OPC3689; N-Cyclohexyl-N-methyl-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide; 6-[3-(N-Cyclohexyl-N-methylcarbamoyl)propoxy]quinolin-2[1H]-one. CAS No. 68550-75-4. Molecular formula: C20H26N2O3. Mole weight: 342.44. | |
| Cilostamide | phosphodiesterase inhibitor. Group: Fluorescence/luminescence spectroscopy. | |
| Cilostamide | Cilostamide. Group: Biochemicals. Grades: Purified. CAS No. 68550-75-4. Pack Sizes: 10mg, 50mg. US Biological Life Sciences. | Worldwide |
| Cilostamide - CAS 68550-75-4 | A cell-permeable selective inhibitor of cGMP-inhibited phosphodiesterase (PDE III; IC?? = 70 nM). Group: Fluorescence/luminescence spectroscopy. | |
| Cilostazol | Cilostazol is a potent cyclic nucleotide phosphodiesterase type 3 (PDE3) inhibitor with IC50 of 0.2 μM and inhibitor of adenosine uptake. Uses: Bronchodilator agents. Synonyms: AT2266; CI919; Pd107779; NSC629661; AT 2266; CI 919; Pd 107779; NSC 629661; AT-2266; CI-919; Pd-107779; NSC-629661. Grade: >98%. CAS No. 73963-72-1. Molecular formula: C20H27N5O2. Mole weight: 369.46. | |
| Cilostazol | Cilostazol. Group: Biochemicals. Grades: Purified. CAS No. 73963-72-1. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Cilostazol | Cilostazol (OPC 13013) is a potent and selective inhibitor of phosphodiesterase (PDE) 3A , the isoform of PDE 3 in the cardiovascular system, with an IC 50 of 0.2 μM [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: OPC 13013. CAS No. 73963-72-1. Pack Sizes: 10 mM * 1 mL; 50 mg; 100 mg. Product ID: HY-17464. | |
| Cilostazol | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C20H27N5O2. CAS No. 73963-72-1. Prepack ID 81559665-1g. Molecular Weight 369.46. See USA prepack pricing. |  |
| Cilostazol-[d11] | Cilostazol-[d11] is the labelled analogue of Cilostazol. Cilostazol is a medication used to help the symptoms of intermittent claudication in peripheral vascular disease. Cilostazol is a potent cyclic nucleotide phosphodiesterase type 3 (PDE3) inhibitor with IC50 of 0.2 μM and inhibitor of adenosine uptake. Synonyms: Cilostazol-d11; 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone-d11; OPC-13013-d11; Pletal-d11. Grade: 97% by CP; 98% atom D. CAS No. 1073608-02-2. Molecular formula: C20H16D11N5O2. Mole weight: 380.53. | |
| Cilostazol-d11 (OPC-13013-d11, Pletal-d11, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone) | A potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake. Has antimitogeni, antithrombotic, vasodilatory and cardiotonic properties in vivo. Also affects lipid levels in vivo. Group: Biochemicals. Alternative Names: OPC-13013-d11;Pletal-d11;6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Cilostazol-D2 | Cilostazol-D2. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1073608-03-3. Molecular formula: C20H25D2N5O2. Mole weight: 371.48. Catalog: APB1073608033. | |
| Cilostazol-[d4] | Cilostazol-[d4] is the labelled analogue of Cilostazol. Cilostazol is a medication used to help the symptoms of intermittent claudication in peripheral vascular disease. Cilostazol is a potent cyclic nucleotide phosphodiesterase type 3 (PDE3) inhibitor with IC50 of 0.2 μM and inhibitor of adenosine uptake. Synonyms: Cilostazol D4; 6-[4-(1-Cyclohexyl-d4-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone; Pletal-d4. Grade: 98%; ≥95% atom D. CAS No. 1215541-47-1. Molecular formula: C20H23D4N5O2. Mole weight: 373.49. | |
| Cilostazol-D6 | Cilostazol-D6. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1246641-05-3. Molecular formula: C20H21D6N5O2. Mole weight: 375.51. Catalog: APB1246641053. | |
| Cilostazol Impurity 12-D11 | Cilostazol Impurity 12-D11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1073608-13-5. Molecular formula: C20H14D11N5O2. Mole weight: 378.52. Catalog: APB1073608135. | |
| Cilostazol (OPC-13013, Pletal, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone) | A potent phosphodiesterase III A (PDE3A) inhibitor (IC50=0.2uM) and inhibitor of adenosine uptake. Has antimitogeni, antithrombotic, vasodilatory and cardiotonic properties in vivo. Also affects lipid levels in vivo. Group: Biochemicals. Alternative Names: OPC-13013, Pletal, 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone. Grades: Highly Purified. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Cilostazol Related Compound A | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standards. | |
Our database is helping our users find suppliers everyday.
